Геморрагическая трансформация инфаркта мозга в постинсультном периоде (клиническое наблюдение)

1. Fisher CM, Adams RD. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 1951;10: 92–3.
2. Sussman ES, Connolly ES Jr. Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol 2013; 4: 69.
3. Lyden PD, Zivin JA. Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc Brain Met Rev 1993; 5: 1–16.
4. Alexandrov AV, Black SE, Ehrlich LE et al. Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulants in patients with acute ischemic stroke. Stroke 1997; 28: 1198–202.
5. Hornig CR. Rick evaluation of anticoagulant therapy in cardioembolic stroke. In: Stroke prevention. Eds W.Dorndorf, P.Marx. Basel: Karger, 1994; p. 165–79.
6. Батищева Е.И., Кузнецов А.Н. Геморрагическая трансформация инфаркта головного мозга: клинико-радиологические варианты, факторы риска, прогностическое значение. Неврол. журн. 2008; 5: 29–34.
7. Hsia AW, Luby M, Farber J et al. Abstract T P36: Classification of Hemorrhagic Transformation by ECASS II Criteria More Severe on MRI Than CT. Stroke 2014; 45 (Suppl. 1): ATP36.
8. Renou P, Sibon I, Tourdias T et al. Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage: a comparison of CT and three MRI sequences. Cerebrovasc Dis 2010; 29 (6): 597–604.
9. Fiorelli M, Bastianello S, von Kummer R et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I(ECASS I) cohort. Stroke 1999; 30 (11): 2280–4.
10. Toni D, Fiorelli M, Bastianello S et al. Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 1996; 46 (2): 341–5.
11. Berger C, Fiorelli M, Steiner T et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001; 32 (6): 1330–5.
12. Daverat P, Castel JP, Dartigues JF et al. Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 1991; 22: 1–6.
13. Motto C, Ciccone A, Aritzu E et al and the MAST-I Collaborative group. Hemorrhage after an acute ischemic stroke. Stroke 1999; 30: 761–4.
14. Feldmann E. Intracerebral hemorrhage. Stroke 1991; 22: 684–91.
15. Multicentre Acute Stroke Trial-Italy (MAST-1) Group. Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet 1995; 346: 1509–14.
16. Larrue V, von Kummer R, Müller A et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001; 32: 438–41.
17. Molina CA, Alvarez-Sabin J, Montaner J et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002; 33: 1551–6.
18. Pessin MS, Teal PA, Caplan LR. Hemorrhagic infarction: guilt by association Neuroradiol 1991; 12: 1123–6.
19. Lapchak PA. Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment. Curr Neurol Reports 2002; 2 (1): 38–43.
20. Jickling GC, Liu D, Stamova B et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab 2014; 34 (2): 185–99.
21. Zhang J, Yang Y, Sun H, Xing Y. Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Translation Med 2014; 2 (8): 81.
22. Liebeskind DS, Sanossian N, Yong WH et al. CT and early vessel signs reflect clot composition in acute stroke. Stroke 2011; 42: 1237–43.
23. Национальные рекомендации по диагностике и лечению фибрилляции предсердий, 2012. 
24. Верткин А.Л., Скотников А.С., Алгиян Е.А., Ховасова Н.О. Тактика ведения пациентов с мерцательной аритмией на амбулаторном этапе врачом-терапевтом. Земский врач. 2013; 2 (19): 11–5.
25. Стаховская Л.В., Мешкова К.С., Гудкова В.В. Применение новых оральных антикоагулянтов в профилактике кардиоэмболического инсульта у пациентов с фибрилляцией предсердий: от рекомендаций к реальной практике. Лечебное дело. 2015; 3: 50–8. 
26. Kernan WN, Ovbiagele B, Black HR et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45 (7): 2160–236.
27. Atrial-Fibrilation-Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449–57.
28. January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. J Am Coll Cardiol 2014.
29. Scheitz JF, Seiffge DJ, Tütüncü S et al. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke. Stroke 2014; 45: 509–14.
30. Choi J-Y, Seo W-K, Kang SH et al. Statins improve survival in patients with cardiotmbolic stroke. Stroke 2014; 45: 1849–52.

В.В.Гудкова1, Л.В.Губский1, И.Л.Губский1, Г.В.Панов2, Н.Н.Волкова2, А.К.Никогосова1, Т.А.Логунова3, А.Г.Гуцалюк2, В.П.Подерина2, Е.И.Кимельфельд1, Е.В.Усанова1

1 ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава России;
2 ГБУ Госпиталь для ветеранов войн №3 Департамента здравоохранения г. Москвы;
3 ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России